Drugs / DRV
last change Oct 2015 re-read 2 minutes ago

DRV

Developed for
AIDS
Investigated by
Gilead Sciences · Janssen Research & Development, LLC

Trials 1 · a red edge is where a trial was stopped

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01440569 Sep 2011 → Aug 2012 AIDS Gilead Sciences Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DRV ClinicalTrials.gov intervention name — accepted as the source's own label NCT01440569
Route Oral “800 mg (2 x 400 mg tablets) administered orally with food once daily” NCT01440569